Exelixis Inc

-0.36 (-1.61%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)6.85B
Current PE61.24
Forward PE 59.3
2yr Forward PE 22.16
See more stats
Estimates Current Quarter
Revenue$264.06 Million
Adjusted EPS$0.04
See more estimates
10-Day MA$22.17
50-Day MA$22.11
200-Day MA$22.47
See more pivots

Exelixis, Inc. Stock, NASDAQ:EXEL

1851 Harbor Bay, Alameda, California 94502
United States of America
Phone: +1.650.837.7000
Number of Employees: 773


Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. It offers products under the brands of COMETRIQ, CABOMETYX, COTELLIC, and MINNEBRO. The company was founded by Corey S. Goodman and Stelios B. Papadopoulos on November 15, 1994 and is headquartered in Alameda, CA.